Modelling the cost-effectiveness of human milk and breastfeeding in preterm infants in the United Kingdom

Victora CG, Bahl R, Barros AJD, et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387(10017):475–90.

World Health Organization. (2001, May 1). The World Health Organization’s infant feeding recommendation. Retrieved September 09, 2015, from http://www.who.int/nutrition/topics/infantfeeding_recommendation/en/ .

World Health Organization. (2014, December 30). Global Nutrition Targets 2025: Breastfeeding policy brief. Retrieved September 09, 2015, from http://apps.who.int/iris/bitstream/10665/149022/1/WHO_NMH_NHD_14.7_eng.pdf?ua=1

McAndrew F, Thompson J, Fellows L, et al. Infant Feeding Survey 2010. The Health and Social Care Information Centre. 2012.

Dyson L, McCormick FM, Renfrew MJ. Interventions for promoting the initiation of breastfeeding. Cochrane Database Syst Rev. 2005;2, CD001688.

Maastrup R, Hansen BM, Kronbord H, et al. Factors associated with exclusive breastfeeding of preterm infants. Results from a prospective national cohort study. PLoS ONE. 2014;9(2):e89077.

Bonet M, Blondel B, Agostino R, et al. Variations in breastfeeding rates for very preterm infants between regions and neonatal units in Europe: results from the MOSAIC cohort. Arch Dis Child Fetal Neonatal Ed. 2011;96(6):F450–2.

Boyd CA, Quigley MA, Brocklehurst P. Donor breast milk versus infant formula for preterm infants: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2007;92(3):F169–75.

Renfrew M, Pohkrel S, Quigley M, et al. Preventing disease and saving resources: the potential contribution of increasing breastfeeding rates in the UK. London: UNICEF; 2012.

Pokhrel S, Quigley MA, Fox-Rushby J, et al. Potential economic impacts from improving breastfeeding rates in the UK. Arch Dis Child. 2015;100(4):334–40.

Rollins NC, Bhandari N, Hajeebhoy N, et al. Why invest, and what it will take to improve breastfeeding practices? Lancet. 2016;387(10017):491–504.

Horta BL, Victora CG. Long-term effects of breastfeeding: A systematic review. Geneva: World Health Organisation; 2013.

Renfrew MJ, Craig D, Dyson L, et al. Breastfeeding promotion for infants in neonatal units: a systematic review and economic analysis. Health Technol Assess. 2009;13(40):1–146. iii-iv.

Office for National Statistics (2015). Gestation-specific infant mortality in England and Wales, 2013. Number of births. Available online at: http://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/causesofdeath/bulletins/pregnancyandethnicfactorsinfluencingbirthsandinfantmortality/2013-10-10 . Accessed 15 June 2016.

Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296(13):716–21.

National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisal 2013. April 2013. Available from https://www.nice.org.uk/process/pmg9/chapter/foreword . Accessed 8 June 2016.

Quigley M, McGuire W. Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database of Syst Rev. 2014;4, CD002971.

Department for Business Innovation and Skills. The Impact of University Degrees on the Lifecycle of Earnings. 2013. August 2013. BIS Research Paper no. 112.

Vohr BR, Wright LL, Dusick AM, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993–1994. Pediatrics. 2000;105(6):1216–26.

Kramer MS, Kakuma R. The optimal duration of exclusive breastfeeding: a systematic review. Adv Exp Med Biol. 2004;554:63–77.

Guthrie SO, Gordon PV, Thomas V, et al. Necrotizing enterocolitis among neonates in the United States. J Perinatol. 2003;23(4):278–85.

Schanler RJ, Lau C, Hurst NM, Smith EO. Randomized trial of donor human milk versus preterm formula as substitutes for mothers’ own milk in the feeding of extremely premature infants. Pediatrics. 2005;116(2):400–6.

Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet. 1990;336(8730):1519–23.

Health & Social Care Information Centre (2013). Hospital Episode Statistics, admitted patient care, England - 2012–2013: Diagnosis. Available online at: http://www.hscic.gov.uk/catalogue/PUB12566/hosp-epis-stat-admi-summ-rep-2012-13-rep.pdf

Department of Health. NHS Reference Costs 2012–2013. Available online at: https://www.gov.uk/government/publications/nhs-reference-costs-2012-to-2013 . Accessed 15 June 2016.

Fanaroff AA, Korones SB, Wright LL, et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J. 1998;17(7):593–8.

Vohr BR, Poindexter BB, Dusick AM, et al. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age. Pediatrics. 2006;118:e115–23.

Hintz SR, Kendrick DE, Stoll BJ, et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics. 2005;115(3):696–703.

Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low birth- weight infants with neonatal infection. JAMA. 2004;292(19):2357–65.

NHS Scotland, Information and Statistics Division. Small Infants in Scotland. Available online at: http://www.isdscotland.org/health-Topics/Maternity-and-Births/Stillbirth-and-Infant-Deaths/mat_bb_small_babies.pdf .

Office for National Statistics (2015). National life tables, United Kingdom: 2012–2014. Available online at: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/lifeexpectancies/bulletins/nationallifetablesunitedkingdom/2015-09-23 . Accessed 15 June 2016.

Dolan P, Gudex C, King P, Williams A. A social tariff for EuroQol: results from a UK general population survey. Discussion Paper 138. York: University of York, Centre for Health Economics; 1995.

Office for National Statistics (2015). Unexplained deaths in infancy: England and Wales: 2013. Available online at: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/unexplaineddeathsininfancyenglandandwales/2015-08-19 . Accessed 15 June 2016.

Hauck FR, Thompson JMD, Tanabe KO, et al. Breastfeeding and reduced risk of sudden infant death syndrome: A meta-analysis. Pediatrics. 2011;128(1):103–10.

Fisk CM, Crozier SR, Inskip HM, et al. Breastfeeding and reported morbidity during infancy: findings from the Southampton Women’s Survey. Matern Child Nutr. 2011;7(1):61–70.

Curtis L. Unit costs of health and social care. Canterbury: Personal Social Services Research Unit, University of Kent; 2014.

Scottish Intercollegiate Guidelines Network (SIGN). Long term follow up of survivors of childhood cancer. Edinburgh: SIGN; 2013. (SIGN publication no. 132). [March 2013]. Available from URL: http://www.sign.ac.uk

Martin RM, Gunnel D, Owen CG, Smith GD. Breast-feeding and childhood cancer: a systematic review with meta analysis. Int J Cancer. 2005;117(6):1020–31.

Rahiala J, Riikonen P, Kekalainen L, Perkkio M. Cost analysis of the treatment of acute childhood lymphocytic leukaemia according to Nordic protocols. Acta Paediatr. 2000;89(4):482–7.

Vora A, Goulden N, Wade R, et al. Treatment reduction for children and young adults with low-risk acute lumphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. Lancet Oncol. 2013;14(3):199–209.

Rae C, Furlong W, Jankovic M, et al. Economic evaluation of treatment for acute lymphoblastic leukaemia in childhood. Eur J Cancer Care (Engl). 2014;23(6):779–85.

Department of Health. National Childrens Measurement Programme. 2011.

Freedman DS, Khan LK, Serdula MK, et al. The relation of childhood BMI to adult adiposity: the Bogalusa Heart Study. Pediatrics. 2005;115(1):22–7.

McQuigg M, Brown JE, Broom J, et al. The CounterWeight programme: Prevalence of CVD risk factors by body mass index and the impact of 10% weight change. Obes Res Clin Pract. 2008;2(1):I–II.

Ara R, Brennan A. The cost-effectiveness of sibutramine in non-diabetes obese patients: evidence from four Western countries. Obes Rev. 2007;8(4):363–71.

YHPHO Yorkshire and Humber Public Health Observatory. Diabetes Key Facts. March 2006. Available from URL: www.yhpho.org.uk/resource/view.aspx?RID=8872 .

Larroque B, Ancel PY, Marret S, et al. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study. Lancet. 2008;371(9615):813–20.

Colbourn T, Asseburg C, Bojke L, et al. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost effectiveness and expected value of information analyses. Health Technol Assess. 2007;11(29):1–226. iii.